4-hydroxymephenytoin has been researched along with Heart Failure in 1 studies
*Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feldman, AM; Frye, CS; Frye, RF; Schneider, VM | 1 |
1 other study(ies) available for 4-hydroxymephenytoin and Heart Failure
| Article | Year |
|---|---|
Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure.
Topics: Adult; Aged; Biomarkers; Cytochrome P-450 Enzyme System; Dextromethorphan; Excitatory Amino Acid Antagonists; Female; Genetic Markers; Genotype; Heart Failure; Humans; Interleukin-6; Male; Mephenytoin; Middle Aged; Mutation; Phenotype; Polymorphism, Genetic; Prevalence; Statistics as Topic; Tumor Necrosis Factor-alpha | 2002 |